Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 2/20 | 0.33 |
| ▸ | RARG | P13631 | 2/20 | 0.33 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5439349 | 1.00 | MEN1 (0.39) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL5441829 | 0.81 | TRPA1 (0.40) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL5441832 | 0.81 | TRPA1 (0.40) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL5442565 | 0.80 | RARB (0.37) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL21574083 | 0.79 | MEN1 (0.46) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL12880518 | 0.76 | PTPN1 (0.48) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL3148661 | 0.75 | MEN1 (0.44) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL15082353 | 0.74 | RARB (0.41) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL3414622 | 0.74 | RARB (0.41) | MEN1KMT2ALMNATRPA1ALDH1A1 | |
| SCHEMBL15435465 | 0.73 | ALDH1A1 (0.38) | MEN1KMT2ALMNATRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070189984-A1 | Agents for use on skin and/or hair containing quadruply substituted cyclohexene compounds | BEIERSDORF AF, (DE) | 2007-08-16 | — | — | US | claimed |
| EP-1675560-A1 | AGENTS FOR USE ON SKIN AND/OR HAIR CONTAINING QUADRUPLY SUBSTITUTED CYCLOHEXENE COMPOUNDS | Beiersdorf AG (DE) | 2006-07-05 | — | — | EP | claimed |
| WO-2005032501-A1 | AGENTS FOR USE ON SKIN AND/OR HAIR CONTAINING QUADRUPLY SUBSTITUTED CYCLOHEXENE COMPOUNDS | BEIERSDORF AG (DE) | 2005-04-14 | — | — | WO | claimed |
| US-20070189984-A1 | Agents for use on skin and/or hair containing quadruply substituted cyclohexene compounds | BEIERSDORF AF, (DE) | 2007-08-16 | — | — | US | disclosed |
| EP-1675560-A1 | AGENTS FOR USE ON SKIN AND/OR HAIR CONTAINING QUADRUPLY SUBSTITUTED CYCLOHEXENE COMPOUNDS | Beiersdorf AG (DE) | 2006-07-05 | — | — | EP | disclosed |
| WO-2005032501-A1 | AGENTS FOR USE ON SKIN AND/OR HAIR CONTAINING QUADRUPLY SUBSTITUTED CYCLOHEXENE COMPOUNDS | BEIERSDORF AG (DE) | 2005-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070189984-A1 | Agents for use on skin and/or hair containing quadruply substituted cyclohexene compounds | TYR, MC1R, MITF | MEN1 1669/4885KMT2A 2509/4885LMNA 783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.